The Victorian contaminant remains unnamed and under investigation
Success in the next decade will be determined by the ability of pharmaceutical innovators to balance the defense of their existing patent thickets with the rapid commercialization of next-generation modalities that redefine the therapeutic standard of care
While the LIVE and FIGHT trials explored their effects on heart failure with reduced ejection fraction (HFrEF), the STEP-HFpEF trial demonstrated that GLP-1RAs improve HFpEF outcomes by reducing symptoms, physical limitations, and body weight [9]
Compounded drugs are prepared in compliance with pharmacy standards but do not undergo the same rigorous testing as FDA-approved products
The comfort of home is now the new waiting room, and the days of long queues and in-person visits are over
Its important to note that GLP-1 agonists are not approved for use in Type 1 diabetes in Canada, although they may occasionally be prescribed off-label in unique circumstances